1alpha,25-Dihydroxyvitamin D 3 Inhibits Normal Human Keratinocyte Growth by Increasing Transforming Growth Factor beta2 Release

By Haugen J.D.   Pittelkow M.R.   Zinsmeister A.R.   Kumar R.  

Biochemical and Biophysical Research Communications, Vol. 229, Iss. 2, 1996-12 ,pp. : 618-623

Elsevier

Access to resources Recommend Favorite

Transforming Growth Factor beta1 Increases the Synthesis and Shedding of the Melanoma-Specific Proteoglycan in Human Melanoma Cells

By Heredia A.   Villena J.   Romaris M.   Molist A.   Bassols A.  

Archives of Biochemistry and Biophysics, Vol. 333, Iss. 1, 1996-09 ,pp. : 198-206

Elsevier

Access to resources Recommend Favorite

Mutation Analysis of the Transforming Growth Factor beta Type II Receptor in Sporadic Human Cancers of the Pancreas, Liver, and Breast

By Vincent F.   Hagiwara K.   Ke Y.   Stoner G.D.   demetrick D.J.   Bennett W.P.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 3, 1996-06 ,pp. : 561-564

Elsevier

Access to resources Recommend Favorite

1,25-Dihydroxyvitamin D3 Regulates the Expression of N-myc, c-myc, Protein Kinase C, and Transforming Growth Factor-beta2 in Neuroblastoma Cells

By Veenstra T.D.   Windebank A.J.   Kumar R.  

Biochemical and Biophysical Research Communications, Vol. 235, Iss. 1, 1997-06 ,pp. : 15-18

Elsevier

Access to resources Recommend Favorite

Expression of Recombinant Human Soluble Type II Transforming Growth Factor-beta Receptor in Pichia pastoris and Escherichia coli: Two Powerful Systems to Express a Potent Inhibitor of Transforming Growth Factor-beta

By Glansbeek H.L.   van Beuningen H.M.   Vitters E.L.   van der Kraan P.M.   van den Berg W.B.  

Protein Expression and Purification, Vol. 12, Iss. 2, 1998-03 ,pp. : 201-207

Academic Press

Access to resources Recommend Favorite